CORC  > 武汉大学
Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival
Zhang, Wu; Zhao, Chen; Zhao, Junmei; Zhu, Yongmei; Weng, Xiangqin; Chen, Qiusheng; Sun, Huiping; Mi, Jian-Qing; Li, Junmin; Zhu, Jiang
刊名THERANOSTICS
2018
卷号8期号:16
关键词NPM1 mutation H3K79 hypermethylation PBX3 HOXA9 DOT1L inhibitor
ISSN号1838-7640
DOI10.7150/thno.26900
URL标识查看原文
收录类别SCIE
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4155466
专题武汉大学
推荐引用方式
GB/T 7714
Zhang, Wu,Zhao, Chen,Zhao, Junmei,et al. Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival[J]. THERANOSTICS,2018,8(16).
APA Zhang, Wu.,Zhao, Chen.,Zhao, Junmei.,Zhu, Yongmei.,Weng, Xiangqin.,...&Xu, Jie.(2018).Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival.THERANOSTICS,8(16).
MLA Zhang, Wu,et al."Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival".THERANOSTICS 8.16(2018).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace